Association Between the Frailty and Cognitive Impairment Among Patients With Hypertension-A Post Hoc Analysis of the SPRINT Trial.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
04 04 2023
Historique:
medline: 5 4 2023
pubmed: 29 3 2023
entrez: 28 3 2023
Statut: ppublish

Résumé

Background Frailty and cognitive impairment are common in the elderly, with various shared risk factors like hypertension. Frailty is a marker for future cognitive function. Moreover, whether intensive blood pressure interacted with frailty and cognitive impairment is unknown. Methods and Results We performed a post hoc analysis of data from SPRINT (Systolic Blood Pressure Intervention Trial). The relationship between frailty and a composite of probable dementia (PD) and mild cognitive impairment (MCI) was analyzed. Also, we evaluated the interaction of intensive blood pressure lowering in the relationship between frailty and cognitive impairment. A total of 8537 patients were included in our study, and 35.1% were women. The mean age of these participants was 67.9±9.3 years. According to the baseline frailty index, 1670, 4637, and 2230 patients were in fit, less fit, and frail statuses, respectively. During a mean follow-up of 4.61 years, 871 cases of PD or MCI occurred. Compared with those in fit status, those with less fit (hazard ratio [HR], 2.14 [95% CI, 1.65-2.77]) and frailty (HR, 4.28 [95% CI, 3.26-5.61]) status had a higher incidence of a composite of PD and MCI. Blood pressure control strategy interacted with the correlation between frailty and cognitive impairment. Intensive blood pressure control (HR, 2.4 [95% CI, 2.0-2.8]) accelerated the relationship between frailty and incidence of PD and MCI compared with the standard treatment group (HR, 1.8 [95% CI, 1.5-2.1];

Identifiants

pubmed: 36974773
doi: 10.1161/JAHA.122.028736
pmc: PMC10122877
doi:

Substances chimiques

Antihypertensive Agents 0

Banques de données

ClinicalTrials.gov
['NCT01206062']

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e028736

Références

Clin Trials. 2014 Oct;11(5):532-46
pubmed: 24902920
J Neurol Neurosurg Psychiatry. 2022 Apr;93(4):343-350
pubmed: 34933996
BMC Med. 2021 Oct 18;19(1):248
pubmed: 34657626
J Ambul Care Manage. 2006 Oct-Dec;29(4):310-9
pubmed: 16985389
J Am Geriatr Soc. 2020 Mar;68(3):496-504
pubmed: 31840813
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
Panminerva Med. 2012 Sep;54(3):179-88
pubmed: 22801435
Ageing Res Rev. 2013 Sep;12(4):840-51
pubmed: 23831959
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
JAMA Intern Med. 2014 Mar;174(3):324-33
pubmed: 24493100
BMC Neurol. 2018 Nov 26;18(1):193
pubmed: 30477436
Lancet Public Health. 2022 Feb;7(2):e105-e125
pubmed: 34998485
J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7):738-43
pubmed: 17634321
Arch Intern Med. 2002 Oct 14;162(18):2046-52
pubmed: 12374512
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
J Gerontol A Biol Sci Med Sci. 2021 May 22;76(6):1134-1143
pubmed: 33420508
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
J Gerontol A Biol Sci Med Sci. 2016 May;71(5):649-55
pubmed: 26755682
Int Psychogeriatr. 2021 Oct;33(10):1035-1043
pubmed: 33586645
Lancet Neurol. 2008 Aug;7(8):683-9
pubmed: 18614402
J Am Med Dir Assoc. 2022 Nov;23(11):1807-1814
pubmed: 35283085
J Am Med Dir Assoc. 2016 Oct 1;17(10):881-8
pubmed: 27324809
Alzheimers Res Ther. 2015 Aug 03;7(1):54
pubmed: 26240611
JAMA. 2019 Feb 12;321(6):553-561
pubmed: 30688979
N Engl J Med. 2015 Nov 26;373(22):2103-16
pubmed: 26551272

Auteurs

Zhiyan Wang (Z)

Department of Cardiovascular Medicine Beijing Anzhen Hospital, Capital Medical University Beijing China.

Qinshi Wang (Q)

Department of Clinical Laboratory Changzhou No.2 People's Hospital, Nanjing Medical University Changzhou Jiangsu China.

Junyu Pei (J)

Department of Cardiovascular Medicine The Second Xiangya Hospital, Central South University Changsha Hunan China.
Department of Biochemistry and Molecular Biology The Libin Cardiovascular Institute of Alberta, The University of Calgary, Health Sciences Center Calgary Alberta Canada.

Xiaopu Wang (X)

Department of Cardiovascular Medicine The Second Xiangya Hospital, Central South University Changsha Hunan China.
Department of Biochemistry and Molecular Biology The Libin Cardiovascular Institute of Alberta, The University of Calgary, Health Sciences Center Calgary Alberta Canada.

Yanan Li (Y)

School of Public Health Brown University Providence Rhode Island USA.

Jiafu Yan (J)

Department of Cardiology The Affiliated Hospital of Yangzhou University, Yangzhou University Yangzhou Jiangsu China.

Xin Du (X)

Department of Cardiovascular Medicine Beijing Anzhen Hospital, Capital Medical University Beijing China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH